Rapid Delivery of Therapeutics Via Dissolution of Polymeric Films

通过聚合物薄膜的溶解快速递送治疗药物

• 批准号: 539432-2019
• 负责人: Adronov, Alex
• 金额: $ 8.74万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Collaborative Research and Development Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=720644
• 关键词: Rapid; Delivery; Therapeutics; Via; Dissolution

Oral delivery of pharmaceuticals is the most common form of drug administration, and is dominated by the use of tablets and capsules of various forms. However, there are a number of problems associated with tablets that diminish the utility of this form of dose administration. For instance, patients that have difficulty swallowing (children, the elderly, people with severe nausea, and patients suffering from dysphasia) are unable to tolerate solid tablets. In addition, tablets must pass through the gastrointestinal tract, with the therapeutic agents being absorbed through the gut. This takes significant amounts of time, delaying the onset of therapeutic action. Finally, drugs that are swallowed generally undergo metabolism, and can cause liver toxicity. As an alternative to tablets, thin polymer films that rapidly dissolve in the mouth have received significant attention. These films have been introduced in the market by Pfizer as Listerine PocketPaks, and have been a popular breath freshener since 2001. However, these films can also be loaded with pharmaceutical agents for oral drug delivery. This allows a therapeutic dose to be released in the mouth, and to be absorbed through the mucosal membranes directly into the bloodstream, bypassing the stomach and liver. This is advantageous as it results in rapid entry of drugs into circulation, bypasses gastrointestinal metabolism, decreases liver toxicity, and does not require swallowing. However, loading different drug compounds, especially those that are not water soluble, within a rapidly dissolving thin polymer film poses challenges, as different structures will impact film integrity and properties. This proposal aims to investigate new formulations for incorporation and encapsulation of a wide array of drugs within polymer films, and to help the industrial partner (Rapid Dose Therapeutics, Inc.) develop alternative delivery methods for the pharmaceutical industry.

口服给药是最常见的给药形式，以各种形式的片剂和胶囊为主。然而，与片剂相关的一些问题降低了这种剂量给药形式的实用性。例如，吞咽困难的患者(儿童、老年人、严重恶心的人和言语障碍患者)无法耐受固体片剂。此外，片剂必须通过胃肠道，治疗剂通过肠道吸收。这需要大量的时间，延迟了治疗行动的开始。最后，吞咽的药物通常会进行新陈代谢，并可能导致肝脏毒性。作为片剂的替代品，能够在口腔中快速溶解的聚合物薄膜受到了极大的关注。这些薄膜被辉瑞公司作为Listerine PocketPaks推向市场，自2001年以来一直是一种受欢迎的口气清新剂。然而，这些薄膜也可以装载用于口服给药的药剂。这使得治疗性剂量可以在口腔中释放，并通过粘膜直接被吸收到血液中，绕过胃和肝脏。这是有利的，因为它导致药物快速进入循环，绕过胃肠道代谢，降低肝脏毒性，并且不需要吞咽。然而，在快速溶解的聚合物薄膜中装载不同的药物化合物，特别是那些不可溶的药物化合物，会带来挑战，因为不同的结构将影响薄膜的完整性和性能。这项建议旨在研究新的配方，以便在聚合物薄膜中并入和封装各种药物，并帮助工业合作伙伴(快速剂量治疗公司)。为制药业开发替代给药方法。